vs

Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Silvercrest Asset Management Group Inc. (SAMG). Click either name above to swap in a different company.

Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $32.0M, roughly 1.9× Silvercrest Asset Management Group Inc.). Silvercrest Asset Management Group Inc. runs the higher net margin — -0.4% vs -70.9%, a 70.6% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -0.0%). Silvercrest Asset Management Group Inc. produced more free cash flow last quarter ($15.0M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 2.7%).

Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.

CTKB vs SAMG — Head-to-Head

Bigger by revenue
CTKB
CTKB
1.9× larger
CTKB
$62.1M
$32.0M
SAMG
Growing faster (revenue YoY)
CTKB
CTKB
+8.1% gap
CTKB
8.1%
-0.0%
SAMG
Higher net margin
SAMG
SAMG
70.6% more per $
SAMG
-0.4%
-70.9%
CTKB
More free cash flow
SAMG
SAMG
$16.7M more FCF
SAMG
$15.0M
$-1.8M
CTKB
Faster 2-yr revenue CAGR
CTKB
CTKB
Annualised
CTKB
17.7%
2.7%
SAMG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTKB
CTKB
SAMG
SAMG
Revenue
$62.1M
$32.0M
Net Profit
$-44.1M
$-120.0K
Gross Margin
52.9%
Operating Margin
-9.0%
-2.8%
Net Margin
-70.9%
-0.4%
Revenue YoY
8.1%
-0.0%
Net Profit YoY
-557.1%
-107.4%
EPS (diluted)
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTKB
CTKB
SAMG
SAMG
Q4 25
$62.1M
$32.0M
Q3 25
$52.3M
$31.3M
Q2 25
$45.6M
$30.7M
Q1 25
$41.5M
$31.4M
Q4 24
$57.5M
$32.0M
Q3 24
$51.5M
$30.4M
Q2 24
$46.6M
$31.0M
Q1 24
$44.9M
$30.3M
Net Profit
CTKB
CTKB
SAMG
SAMG
Q4 25
$-44.1M
$-120.0K
Q3 25
$-5.5M
$618.0K
Q2 25
$-5.6M
$1.9M
Q1 25
$-11.4M
$2.5M
Q4 24
$9.6M
$1.6M
Q3 24
$941.0K
$2.3M
Q2 24
$-10.4M
$2.7M
Q1 24
$-6.2M
$3.0M
Gross Margin
CTKB
CTKB
SAMG
SAMG
Q4 25
52.9%
Q3 25
52.7%
Q2 25
52.3%
Q1 25
48.6%
Q4 24
58.5%
Q3 24
56.3%
Q2 24
54.6%
Q1 24
51.3%
Operating Margin
CTKB
CTKB
SAMG
SAMG
Q4 25
-9.0%
-2.8%
Q3 25
-17.6%
4.3%
Q2 25
-23.3%
13.2%
Q1 25
-36.1%
15.4%
Q4 24
5.2%
6.1%
Q3 24
-8.2%
14.6%
Q2 24
-18.3%
17.1%
Q1 24
-23.9%
19.5%
Net Margin
CTKB
CTKB
SAMG
SAMG
Q4 25
-70.9%
-0.4%
Q3 25
-10.5%
2.0%
Q2 25
-12.2%
6.3%
Q1 25
-27.5%
7.9%
Q4 24
16.8%
5.1%
Q3 24
1.8%
7.4%
Q2 24
-22.4%
8.6%
Q1 24
-13.8%
9.9%
EPS (diluted)
CTKB
CTKB
SAMG
SAMG
Q4 25
$0.02
Q3 25
$0.07
Q2 25
$0.21
Q1 25
$0.26
Q4 24
$0.16
Q3 24
$0.24
Q2 24
$0.28
Q1 24
$0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTKB
CTKB
SAMG
SAMG
Cash + ST InvestmentsLiquidity on hand
$90.9M
$44.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$341.7M
$50.3M
Total Assets
$461.5M
$166.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTKB
CTKB
SAMG
SAMG
Q4 25
$90.9M
$44.1M
Q3 25
$93.3M
$36.1M
Q2 25
$75.5M
$30.0M
Q1 25
$95.3M
$36.3M
Q4 24
$98.7M
$68.6M
Q3 24
$162.3M
$58.1M
Q2 24
$177.9M
$49.9M
Q1 24
$168.8M
$39.7M
Stockholders' Equity
CTKB
CTKB
SAMG
SAMG
Q4 25
$341.7M
$50.3M
Q3 25
$378.6M
$58.9M
Q2 25
$377.6M
$64.6M
Q1 25
$379.6M
$80.0M
Q4 24
$395.7M
$80.7M
Q3 24
$385.5M
$84.6M
Q2 24
$389.1M
$85.3M
Q1 24
$392.6M
$83.9M
Total Assets
CTKB
CTKB
SAMG
SAMG
Q4 25
$461.5M
$166.6M
Q3 25
$494.9M
$157.6M
Q2 25
$493.3M
$152.7M
Q1 25
$482.6M
$159.9M
Q4 24
$499.5M
$194.4M
Q3 24
$491.2M
$184.2M
Q2 24
$483.7M
$177.6M
Q1 24
$492.1M
$170.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTKB
CTKB
SAMG
SAMG
Operating Cash FlowLast quarter
$-771.0K
$18.6M
Free Cash FlowOCF − Capex
$-1.8M
$15.0M
FCF MarginFCF / Revenue
-2.9%
46.9%
Capex IntensityCapex / Revenue
1.6%
11.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-8.8M
$17.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTKB
CTKB
SAMG
SAMG
Q4 25
$-771.0K
$18.6M
Q3 25
$-3.9M
$14.6M
Q2 25
$108.0K
$13.8M
Q1 25
$-125.0K
$-24.7M
Q4 24
$2.0M
$21.6M
Q3 24
$13.2M
$13.3M
Q2 24
$6.2M
$16.0M
Q1 24
$4.0M
$-24.1M
Free Cash Flow
CTKB
CTKB
SAMG
SAMG
Q4 25
$-1.8M
$15.0M
Q3 25
$-4.6M
$13.8M
Q2 25
$-1.5M
$13.4M
Q1 25
$-974.0K
$-25.1M
Q4 24
$1.1M
$19.9M
Q3 24
$12.2M
$12.9M
Q2 24
$5.2M
$15.6M
Q1 24
$3.4M
$-24.7M
FCF Margin
CTKB
CTKB
SAMG
SAMG
Q4 25
-2.9%
46.9%
Q3 25
-8.7%
44.1%
Q2 25
-3.2%
43.6%
Q1 25
-2.3%
-80.0%
Q4 24
1.9%
62.2%
Q3 24
23.7%
42.4%
Q2 24
11.0%
50.4%
Q1 24
7.6%
-81.6%
Capex Intensity
CTKB
CTKB
SAMG
SAMG
Q4 25
1.6%
11.4%
Q3 25
1.3%
2.6%
Q2 25
3.5%
1.5%
Q1 25
2.0%
1.3%
Q4 24
1.6%
5.3%
Q3 24
2.0%
1.2%
Q2 24
2.3%
1.1%
Q1 24
1.3%
2.0%
Cash Conversion
CTKB
CTKB
SAMG
SAMG
Q4 25
Q3 25
23.62×
Q2 25
7.22×
Q1 25
-10.01×
Q4 24
0.21×
13.34×
Q3 24
14.05×
5.90×
Q2 24
6.00×
Q1 24
-8.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTKB
CTKB

Products$46.6M75%
Services$15.5M25%

SAMG
SAMG

Investment Advisory Management And Administrative Service$30.7M96%
Tax And Family Office Services$1.2M4%

Related Comparisons